Andere Kunden interessierten sich auch für
![Vascular Perfusion in Cancer Therapy]( "Vascular Perfusion in Cancer Therapy")
Vascular Perfusion in Cancer Therapy77,99 €![Endocrine Therapy of Breast Cancer III]( "Endocrine Therapy of Breast Cancer III")
Endocrine Therapy of Breast Cancer III77,99 €![Current Cancer Therapeutics]( "Current Cancer Therapeutics")
Current Cancer Therapeutics40,99 €![Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II]( "Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II")
Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II77,99 €![Chemosensitivity Testing in Oncology]( "Chemosensitivity Testing in Oncology")
Chemosensitivity Testing in Oncology116,99 €![Focal Liver Lesions]( "Focal Liver Lesions")
Focal Liver Lesions184,99 €![Adjuvant Therapy of Breast Cancer V]( "Adjuvant Therapy of Breast Cancer V")
Adjuvant Therapy of Breast Cancer V77,99 €
This is the first comprehensive book devoted exclusively to cancer in adolescents and young adults. It compiles medical, epidemiological, biological, psychological, and emotional issues of young adults' oncology. The emphasis is on the differences of the "same" cancer in younger and older patients. Model programs specially designed to care for patients in the age group and surveillance of long-term adverse effects are reviewed.
Archie. Bleyer. -. Karen. H . Albritton. -. . Lynn. A G . Ries. -. Ronald. Barr contents 1. 1 introduction 1. 1 introduction. . . . . . . . . . . . . . . . . . . . . . . . . 1 Tis is the frst textbook of its type, a comprehensive 1. 2 epidemiology. . . . . . . . . . . . . . . . . . . . . . . . 2 treatise on cancer in adolescents and young adults who . 1 2 1. Classifcation. System . . . . . . . . . . . . . . . 2 . 1 2 2 . Incidence. . . . . . . . . . . . . . . . . . . . . . 3 are 15 to 29 years of age when diagnosed. Te impetus . 1 2 2 1. Age-Specifc. Incidence . . . . . . 3 for this book is the lack of attention that has been paid . 1 2 2 2 . Gender-Specifc. Incidence. . . . 3 to this age group, scientifcally, therapeutically, psych -o . 1 2 2 3. Ethnicity-Specifc. Incidence. . . 4 socially, and economically. During the past half-cen- . 1 2 2 4. Types. of . Cancer. . . . . . . . . . . 4 tury, children (younger than 15 years of age) with can- . 1 2 2 5. Trends. in. Incidence. . . . . . . . . 6 . 1 2 3. Mortality. and. Survival. . . . . . . . . . . . . . 7 cer have been a singular focus of treatment and . 1 2 3 1. . Age-. and. Gender-Specifc. research. Te advances among children with cancer Mortality. . . . . . . . . . . . . . . 7 have been among the most dramatic in the history of . 1 2 3 2 . Ethnicity-Specifc. Mortality. . . . 8 medicine, and the cooperative infrastructure that has . 1 2 3 3. Trends. in. Mortality. . . . . . . . . 8 supported this success has been among the most orga- . 1 2 4. Survival. . . . . . . . . . . . . . . . . . . . . . . 9 . 1 2 4 1. Conditional. Survival. . . . . . . 12 nized in the history of science. In 1971, the US National . 1 2 5. Etiology. and. Risk. Factors. . . . . . . . . . .
Archie. Bleyer. -. Karen. H . Albritton. -. . Lynn. A G . Ries. -. Ronald. Barr contents 1. 1 introduction 1. 1 introduction. . . . . . . . . . . . . . . . . . . . . . . . . 1 Tis is the frst textbook of its type, a comprehensive 1. 2 epidemiology. . . . . . . . . . . . . . . . . . . . . . . . 2 treatise on cancer in adolescents and young adults who . 1 2 1. Classifcation. System . . . . . . . . . . . . . . . 2 . 1 2 2 . Incidence. . . . . . . . . . . . . . . . . . . . . . 3 are 15 to 29 years of age when diagnosed. Te impetus . 1 2 2 1. Age-Specifc. Incidence . . . . . . 3 for this book is the lack of attention that has been paid . 1 2 2 2 . Gender-Specifc. Incidence. . . . 3 to this age group, scientifcally, therapeutically, psych -o . 1 2 2 3. Ethnicity-Specifc. Incidence. . . 4 socially, and economically. During the past half-cen- . 1 2 2 4. Types. of . Cancer. . . . . . . . . . . 4 tury, children (younger than 15 years of age) with can- . 1 2 2 5. Trends. in. Incidence. . . . . . . . . 6 . 1 2 3. Mortality. and. Survival. . . . . . . . . . . . . . 7 cer have been a singular focus of treatment and . 1 2 3 1. . Age-. and. Gender-Specifc. research. Te advances among children with cancer Mortality. . . . . . . . . . . . . . . 7 have been among the most dramatic in the history of . 1 2 3 2 . Ethnicity-Specifc. Mortality. . . . 8 medicine, and the cooperative infrastructure that has . 1 2 3 3. Trends. in. Mortality. . . . . . . . . 8 supported this success has been among the most orga- . 1 2 4. Survival. . . . . . . . . . . . . . . . . . . . . . . 9 . 1 2 4 1. Conditional. Survival. . . . . . . 12 nized in the history of science. In 1971, the US National . 1 2 5. Etiology. and. Risk. Factors. . . . . . . . . . .
From the reviews: "A comprehensive review of cancer in adolescents between the ages of 15 and 20. ... It is written for students, residents, or practitioners, whether they are general pediatricians, nurses, pediatric oncologists, or other pediatric subspecialists ... . This outstanding book should be a part of every pediatric library. ... an important and beautifully written and illustrated book and is the only one I am aware of that addresses the issue of cancer in adolescents and young adults. ... a must read for pediatric specialists." (Douglas Moodie, Doody's Review Service, April, 2008)